 Katy Trinkley
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Decision Support Systems, Clinical | 11 | 2025 | 226 | 4.760 |
Why?
| | Long QT Syndrome | 6 | 2025 | 70 | 3.060 |
Why?
| | Pharmacists | 7 | 2019 | 265 | 2.670 |
Why?
| | Primary Health Care | 9 | 2020 | 1738 | 1.850 |
Why?
| | Electronic Health Records | 11 | 2025 | 1069 | 1.520 |
Why?
| | Medical Order Entry Systems | 2 | 2021 | 43 | 1.280 |
Why?
| | Pharmacy Service, Hospital | 3 | 2019 | 90 | 1.270 |
Why?
| | Irritable Bowel Syndrome | 3 | 2015 | 28 | 1.250 |
Why?
| | Lisinopril | 2 | 2020 | 13 | 1.230 |
Why?
| | Heart Failure | 6 | 2023 | 2236 | 1.170 |
Why?
| | Practice Patterns, Physicians' | 5 | 2020 | 1313 | 1.110 |
Why?
| | Physicians | 3 | 2023 | 910 | 0.970 |
Why?
| | Hypertension | 4 | 2020 | 1295 | 0.970 |
Why?
| | Artificial Intelligence | 2 | 2024 | 279 | 0.840 |
Why?
| | Constipation | 3 | 2015 | 94 | 0.830 |
Why?
| | Professional Role | 3 | 2019 | 167 | 0.750 |
Why?
| | Interprofessional Relations | 2 | 2015 | 283 | 0.740 |
Why?
| | Electrocardiography | 4 | 2024 | 629 | 0.710 |
Why?
| | Losartan | 1 | 2020 | 14 | 0.690 |
Why?
| | Angioedema | 1 | 2020 | 16 | 0.680 |
Why?
| | Medication Adherence | 2 | 2025 | 467 | 0.680 |
Why?
| | Pharmaceutical Services | 2 | 2019 | 83 | 0.660 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 213 | 0.630 |
Why?
| | Antihypertensive Agents | 2 | 2020 | 494 | 0.620 |
Why?
| | Antipsychotic Agents | 2 | 2018 | 194 | 0.620 |
Why?
| | Pharmaceutical Preparations | 1 | 2021 | 179 | 0.600 |
Why?
| | Humans | 49 | 2025 | 137585 | 0.600 |
Why?
| | Dementia | 2 | 2018 | 259 | 0.540 |
Why?
| | Pharmacies | 2 | 2019 | 38 | 0.540 |
Why?
| | Community Pharmacy Services | 1 | 2017 | 45 | 0.540 |
Why?
| | Health Personnel | 2 | 2020 | 710 | 0.520 |
Why?
| | Chronic Pain | 2 | 2019 | 262 | 0.520 |
Why?
| | Depression | 4 | 2019 | 1397 | 0.500 |
Why?
| | Program Development | 1 | 2018 | 364 | 0.500 |
Why?
| | Analgesics, Opioid | 3 | 2024 | 1000 | 0.490 |
Why?
| | Nursing Informatics | 1 | 2016 | 27 | 0.490 |
Why?
| | Referral and Consultation | 2 | 2019 | 786 | 0.490 |
Why?
| | Torsades de Pointes | 2 | 2024 | 24 | 0.470 |
Why?
| | Benzodiazepines | 1 | 2016 | 155 | 0.470 |
Why?
| | Students, Pharmacy | 1 | 2016 | 97 | 0.470 |
Why?
| | Patient Transfer | 1 | 2017 | 176 | 0.460 |
Why?
| | Cyclohexanols | 1 | 2014 | 12 | 0.460 |
Why?
| | Education, Pharmacy | 1 | 2016 | 120 | 0.450 |
Why?
| | Fibromyalgia | 1 | 2014 | 52 | 0.440 |
Why?
| | Aged | 15 | 2025 | 23961 | 0.440 |
Why?
| | Stroke Volume | 3 | 2023 | 612 | 0.430 |
Why?
| | Patient Care Team | 2 | 2016 | 631 | 0.430 |
Why?
| | Pain Management | 1 | 2017 | 352 | 0.430 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 250 | 0.430 |
Why?
| | Blood Pressure | 2 | 2020 | 1786 | 0.430 |
Why?
| | Registries | 2 | 2020 | 2035 | 0.420 |
Why?
| | Nurse Practitioners | 1 | 2016 | 138 | 0.420 |
Why?
| | Retrospective Studies | 11 | 2023 | 15657 | 0.420 |
Why?
| | Computer-Assisted Instruction | 1 | 2014 | 66 | 0.410 |
Why?
| | Phentermine | 1 | 2013 | 12 | 0.410 |
Why?
| | Medical Informatics | 1 | 2014 | 101 | 0.400 |
Why?
| | Sleep Wake Disorders | 1 | 2016 | 286 | 0.390 |
Why?
| | Patient Safety | 1 | 2016 | 314 | 0.390 |
Why?
| | Middle Aged | 16 | 2025 | 33479 | 0.390 |
Why?
| | Anti-Obesity Agents | 1 | 2013 | 57 | 0.390 |
Why?
| | Fructose | 1 | 2013 | 112 | 0.390 |
Why?
| | Telemedicine | 3 | 2020 | 862 | 0.380 |
Why?
| | Cooperative Behavior | 1 | 2015 | 451 | 0.380 |
Why?
| | Program Evaluation | 3 | 2025 | 898 | 0.380 |
Why?
| | User-Computer Interface | 1 | 2013 | 159 | 0.370 |
Why?
| | Metformin | 1 | 2015 | 331 | 0.370 |
Why?
| | Patient Discharge | 1 | 2017 | 897 | 0.350 |
Why?
| | Pharmacogenetics | 2 | 2024 | 180 | 0.340 |
Why?
| | Male | 20 | 2025 | 67762 | 0.310 |
Why?
| | Ambulatory Care | 3 | 2023 | 546 | 0.310 |
Why?
| | Internet | 1 | 2014 | 655 | 0.310 |
Why?
| | Anxiety | 1 | 2016 | 1035 | 0.300 |
Why?
| | Female | 20 | 2025 | 73304 | 0.290 |
Why?
| | Focus Groups | 2 | 2023 | 522 | 0.290 |
Why?
| | Public Health | 1 | 2013 | 588 | 0.280 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1329 | 0.280 |
Why?
| | Cytochrome P-450 CYP2C19 | 2 | 2024 | 25 | 0.260 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1291 | 0.250 |
Why?
| | Cross-Sectional Studies | 4 | 2023 | 5472 | 0.250 |
Why?
| | Behavior | 2 | 2019 | 90 | 0.250 |
Why?
| | Delivery of Health Care | 2 | 2024 | 951 | 0.240 |
Why?
| | Reproducibility of Results | 3 | 2025 | 3284 | 0.240 |
Why?
| | Pain | 1 | 2010 | 756 | 0.230 |
Why?
| | Patient Participation | 2 | 2020 | 420 | 0.220 |
Why?
| | Treatment Outcome | 5 | 2020 | 10811 | 0.210 |
Why?
| | Naloxone | 1 | 2024 | 122 | 0.210 |
Why?
| | Disease Management | 2 | 2020 | 628 | 0.210 |
Why?
| | Prescriptions | 1 | 2023 | 67 | 0.200 |
Why?
| | Aged, 80 and over | 4 | 2020 | 7635 | 0.200 |
Why?
| | Cardiovascular Agents | 1 | 2025 | 159 | 0.200 |
Why?
| | Reminder Systems | 1 | 2025 | 169 | 0.200 |
Why?
| | Multifactorial Inheritance | 1 | 2024 | 174 | 0.200 |
Why?
| | Narcotic Antagonists | 1 | 2024 | 181 | 0.200 |
Why?
| | Antidepressive Agents | 2 | 2017 | 236 | 0.190 |
Why?
| | Text Messaging | 1 | 2025 | 157 | 0.190 |
Why?
| | Adult | 10 | 2025 | 37929 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2020 | 2057 | 0.190 |
Why?
| | Triage | 1 | 2024 | 222 | 0.190 |
Why?
| | Evidence-Based Practice | 1 | 2024 | 229 | 0.180 |
Why?
| | Surveys and Questionnaires | 4 | 2025 | 5778 | 0.180 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2015 | 2531 | 0.180 |
Why?
| | Physical Therapy Modalities | 1 | 2024 | 308 | 0.180 |
Why?
| | Behavioral Symptoms | 2 | 2018 | 42 | 0.170 |
Why?
| | Psychometrics | 1 | 2025 | 720 | 0.170 |
Why?
| | Inpatients | 1 | 2025 | 500 | 0.170 |
Why?
| | Risk Factors | 4 | 2024 | 10388 | 0.170 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 350 | 0.170 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2024 | 463 | 0.170 |
Why?
| | Evaluation Studies as Topic | 1 | 2020 | 180 | 0.160 |
Why?
| | Mental Health Services | 1 | 2025 | 421 | 0.160 |
Why?
| | Prospective Studies | 3 | 2016 | 7604 | 0.160 |
Why?
| | Obesity | 1 | 2013 | 2992 | 0.160 |
Why?
| | Grounded Theory | 1 | 2019 | 36 | 0.150 |
Why?
| | Biological Specimen Banks | 1 | 2020 | 102 | 0.150 |
Why?
| | Drug Administration Schedule | 1 | 2020 | 786 | 0.150 |
Why?
| | Sex Factors | 2 | 2015 | 2071 | 0.150 |
Why?
| | Curriculum | 2 | 2016 | 992 | 0.140 |
Why?
| | Evidence-Based Medicine | 2 | 2014 | 740 | 0.140 |
Why?
| | Medication Therapy Management | 1 | 2019 | 76 | 0.140 |
Why?
| | Residential Facilities | 1 | 2017 | 8 | 0.140 |
Why?
| | United States | 4 | 2018 | 14841 | 0.140 |
Why?
| | Models, Organizational | 1 | 2018 | 151 | 0.140 |
Why?
| | Independent Living | 1 | 2018 | 105 | 0.130 |
Why?
| | Medication Errors | 1 | 2017 | 95 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2020 | 512 | 0.130 |
Why?
| | Chronic Disease | 2 | 2020 | 1793 | 0.130 |
Why?
| | Intersectoral Collaboration | 1 | 2016 | 60 | 0.120 |
Why?
| | Telenursing | 1 | 2016 | 10 | 0.120 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 201 | 0.120 |
Why?
| | Precision Medicine | 1 | 2020 | 429 | 0.120 |
Why?
| | Laxatives | 1 | 2015 | 19 | 0.120 |
Why?
| | Health Care Surveys | 1 | 2017 | 565 | 0.120 |
Why?
| | Cardiovascular Diseases | 2 | 2025 | 2111 | 0.120 |
Why?
| | Office Visits | 1 | 2015 | 93 | 0.120 |
Why?
| | Venlafaxine Hydrochloride | 1 | 2014 | 13 | 0.110 |
Why?
| | Perception | 1 | 2017 | 359 | 0.110 |
Why?
| | Quality Improvement | 2 | 2020 | 1178 | 0.110 |
Why?
| | Drugs, Investigational | 1 | 2014 | 33 | 0.110 |
Why?
| | Systems Integration | 1 | 2014 | 37 | 0.110 |
Why?
| | PubMed | 1 | 2013 | 11 | 0.110 |
Why?
| | Young Adult | 3 | 2016 | 13209 | 0.100 |
Why?
| | Models, Educational | 1 | 2014 | 93 | 0.100 |
Why?
| | Interviews as Topic | 1 | 2016 | 786 | 0.100 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2069 | 0.100 |
Why?
| | Drug Combinations | 1 | 2013 | 343 | 0.090 |
Why?
| | Communication | 1 | 2017 | 879 | 0.090 |
Why?
| | Teaching | 1 | 2014 | 224 | 0.090 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5131 | 0.090 |
Why?
| | Parasympatholytics | 1 | 2010 | 12 | 0.090 |
Why?
| | Antidiarrheals | 1 | 2010 | 15 | 0.090 |
Why?
| | Adolescent | 3 | 2016 | 21513 | 0.090 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2010 | 30 | 0.090 |
Why?
| | Life Style | 1 | 2013 | 490 | 0.080 |
Why?
| | Dietary Fiber | 1 | 2010 | 54 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 2017 | 1171 | 0.080 |
Why?
| | Diarrhea | 1 | 2010 | 184 | 0.080 |
Why?
| | Abdominal Pain | 1 | 2010 | 145 | 0.080 |
Why?
| | Cohort Studies | 1 | 2019 | 5742 | 0.070 |
Why?
| | Colorado | 2 | 2020 | 4565 | 0.070 |
Why?
| | Age Factors | 1 | 2015 | 3295 | 0.070 |
Why?
| | Clinical Competence | 1 | 2016 | 1118 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2010 | 561 | 0.060 |
Why?
| | Drug Overdose | 1 | 2010 | 347 | 0.060 |
Why?
| | Phenethylamines | 1 | 2024 | 23 | 0.060 |
Why?
| | Tertiary Care Centers | 1 | 2024 | 160 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2022 | 499 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 33 | 0.040 |
Why?
| | Sulfonamides | 1 | 2024 | 513 | 0.040 |
Why?
| | Genotype | 1 | 2024 | 1916 | 0.040 |
Why?
| | Quality of Life | 1 | 2010 | 2892 | 0.040 |
Why?
| | Machine Learning | 1 | 2022 | 493 | 0.030 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2020 | 382 | 0.030 |
Why?
| | Long-Term Care | 1 | 2017 | 107 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2024 | 3556 | 0.030 |
Why?
| | Child | 1 | 2016 | 21935 | 0.030 |
Why?
| | Physician-Patient Relations | 1 | 2020 | 548 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2020 | 1477 | 0.030 |
Why?
|
|
Trinkley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|